Search

everythinglearnresearchcommunity

for

Search:↓

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Prolactin may be important for skin growth and immune function.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Various treatments exist for hair loss, but more research is needed for better options.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

A 23-year-old woman with Hashimoto’s thyroiditis improved significantly after a 15-month integrative treatment plan.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.